Pramiracetam

Pramiracetam Uses, Dosage, Side Effects, Food Interaction and all others data.

Pramiracetam has been previously approved in some eastern European countries under the brand names Pramistar, Neupramir, and Remen. It was also previously approved in the United States with orphan drug designation . Pramiracetam has been studied for the use in Alzheimer's disease and as an adjunct treatment to restore cognitive functioning post-electroconvulsive therapy in severe depression .

Trade Name Pramiracetam
Generic Pramiracetam
Pramiracetam Other Names Pramiracetam
Type
Formula C14H27N3O2
Weight Average: 269.389
Monoisotopic: 269.210327121
Groups Approved
Therapeutic Class
Manufacturer
Available Country
Last Updated: September 19, 2023 at 7:00 am
Pramiracetam
Pramiracetam

Innovators Monograph

You find simplified version here Pramiracetam

*** Taking medicines without doctor's advice can cause long-term problems.
Share